Metabolic Monitoring of Geriatric Patients on Second-Generation Antipsychotics at the Ann Arbor VA

被引:1
|
作者
Alkema, Jenny [1 ]
机构
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源
关键词
D O I
10.1016/j.jagp.2013.12.079
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:S72 / S73
页数:2
相关论文
共 50 条
  • [31] Mortality in schizophrenia patients treated with second-generation antipsychotics
    Kelly, DL
    Wehring, H
    Love, RC
    McMahon, RP
    Yu, Y
    Conley, RR
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 41 - 41
  • [32] Weight Gain in Asian Patients on Second-generation Antipsychotics
    Mahendran, Rathi
    Hendricks, M.
    Chan, Yiong Huak
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2010, 39 (02) : 118 - 121
  • [33] Metabolic monitoring of pediatric patients prescribed second-generation antipsychotic medication
    Roebuck, Julie Henshaw
    JOURNAL OF CHILD AND ADOLESCENT PSYCHIATRIC NURSING, 2024, 37 (01)
  • [34] Second-generation antipsychotics and the metabolic syndrome in drug-naive adolescents
    Sjo, C.
    Bilenberg, N.
    EUROPEAN PSYCHIATRY, 2016, 33 : S263 - S263
  • [35] Second-generation (atypical) antipsychotics and metabolic effects - A comprehensive literature review
    Newcomer, JW
    CNS DRUGS, 2005, 19 : 1 - 93
  • [36] Metabolic side effects in children and adolescents treated with second-generation antipsychotics
    Alvarez-Segura, M.
    Fraguas, D.
    Merchan, J.
    Leiva, M.
    Barajas, A.
    Arango, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S563 - S563
  • [37] Understanding the Perspective of Youths on Undergoing Metabolic Monitoring While on Second-Generation Antipsychotics: Challenges, Insight, and Implications
    Aouira, Nisreen
    Khan, Sohil
    Heussler, Helen
    Haywood, Alison
    Karaksha, Abdullah
    Bor, William
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2023, 33 (07) : 279 - 286
  • [38] Second-Generation (Atypical) Antipsychotics and Metabolic EffectsA Comprehensive Literature Review
    John W. Newcomer
    CNS Drugs, 2005, 19 (Suppl 1) : 1 - 93
  • [39] Determinants of Metabolic Testing for Patients Treated with Second-Generation Antipsychotics after the FDA Diabetes Warning
    Morrato, Elaine H.
    Druss, Benjamin
    Hartung, Daniel M.
    Valuck, Robert J.
    Thomas, Deborah
    Allen, Richard
    Campagna, Elizabeth
    Newcomer, John W.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S100 - S100
  • [40] Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents
    Correll, CU
    Penzner, JB
    Parikh, UH
    Mughal, T
    Javed, T
    Carbon, M
    Malhotra, AK
    CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2006, 15 (01) : 177 - +